Nasdaq Biotechnology Ishares (IBB) 352.51 $IBB
Advances in Technology, Biotech Changing Humans' Relationship to the Environment
at The Street - Sat Mar 14, 5:05AM CDT
Steve Gullans, co-author of 'Evolving Ourselves,' says technology and biotechnology are creating a world of unnatural selection for humans.
QQQ: 106.36 (+1.02), XBI: 230.96 (+2.53), XLK: 41.86 (+0.37), IBB: 352.60 (+7.27)
3 Biotech ETFs Crushing the Market in 2015 - ETF News And Commentary
Eric Dutram - Zacks Investment Research - Fri Mar 13, 11:02AM CDT
If you are looking for impressive biotech funds consider this trio, as all of its members have gained more than 20 percent so far this year.
BIIB: 420.69 (+7.34), BBC: 33.89 (+0.44), BIB: 167.47 (+6.60), XBI: 230.96 (+2.53), IBB: 352.60 (+7.27), AMGN: 161.92 (+7.66)
Biotech: Too Many Red Flags To Ignore
Fabian Knigge - Seeking Alpha - Wed Mar 11, 8:56AM CDT
In recent financing rounds, Uber and Snapchat were valued at sky-high valuations of $41bn and $19bn, respectively. This prompted discussions about whether or not such valuations are justified or if there is another tech bubble on the horizon...
IBB: 352.60 (+7.27)
Women in ETFs Helping to Propel Careers and Industry Higher
at The Street - Mon Mar 09, 3:07PM CDT
Joanne Hill, the co-founder of Women in ETFs, describes the industry landscape and how the organization is designed to inspire and advance both careers and the industry to new highs.
XLB: 49.68 (-0.16), EWG: 29.94 (+0.75), XBI: 230.96 (+2.53), XLY: 75.90 (+0.74), EWQ: 25.77 (+0.43), IBB: 352.60 (+7.27), XLU: 44.31 (+0.83), TLT: 127.90 (+1.18), XRT: 99.55 (+0.63), XLV: 73.22 (+1.41), XLP: 48.69 (+0.41), SPY: 208.04 (+2.21), QQQ: 106.36 (+1.02), EWU: 18.07 (+0.18), DIA: 179.40 (+1.84), XLK: 41.86 (+0.37), IWM: 123.37 (+0.76), XLF: 24.57 (+0.25), XLE: 75.13 (+0.50)
ISIS Pharmaceuticals Has The Cash To Develop Its Expanding Product Pipeline
Emerging Equities - at Seeking Alpha - Fri Mar 06, 4:03PM CST
BIIB: 420.69 (+7.34), ISIS: 71.92 (+1.26), IBB: 352.60 (+7.27), GSK: 46.93 (+0.56), ETF: 12.45 (unch)
IBB Doesn't Fit The Mantra Of High-Risk High-Reward
Noah Kiedrowski - at Seeking Alpha - Fri Mar 06, 2:03PM CST
IBB: 352.60 (+7.27)
Gilead, Mylan, And J&J: Cheap Compared To Peers
Hedgephone - at Seeking Alpha - Fri Mar 06, 11:32AM CST
JNJ: 100.69 (+1.48), GILD: 101.12 (+1.51), IBB: 352.60 (+7.27), MYL: 60.76 (+1.00)
Either Way - The U.S. Is In Trouble
Individual Trader - at Seeking Alpha - Thu Mar 05, 1:24AM CST
SPY: 208.03 (+2.20), IBB: 352.60 (+7.27), UUP: 26.27 (-0.22), TLT: 127.90 (+1.18)
SBIO Vs. BBC: 2 Innovative Biotech ETFs Head-To-Head - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Wed Mar 04, 11:17AM CST
These newly launched products provide exposure to clinical biotechnology companies and have produced decent gains in the year-to-date frame.
SBIO: 30.73 (+0.32), BBC: 33.89 (+0.44), IBB: 352.60 (+7.27)
NASDAQ Hits 5,000: Does The IPO Market Suggest A Biotech Bubble?
Renaissance Capital IPO Research - Seeking Alpha - Tue Mar 03, 8:07AM CST
The NASDAQ Composite is fast approaching its all-time high from March 2000. On Monday it reached 5,000 for the first time since the tech bubble. Today's technology IPOs look much tamer in number than they did 15 years ago, but a boom in biotech...
QQQ: 106.36 (+1.02), XBI: 230.96 (+2.53), IBB: 352.60 (+7.27)
In 2015, Little Is The New Big
Nicholas Vardy - Seeking Alpha - Tue Mar 03, 12:40AM CST
Editor's note: Originally published on 24 February, 2015 When it comes to stocks, “big” is sometimes little — and “little” is sometimes big. Here I’m referring here to the recent performance of small-cap stocks...
RWJ: 57.33 (unch), IJT: 128.43 (+0.76), IJS: 117.61 (+0.21), IJR: 116.80 (+0.49), SBB: 51.07 (-0.32), VIOO: 104.87 (+0.38), SLY: 107.22 (+0.34), SAA: 118.52 (+1.20), SDD: 37.16 (-0.21), FYX: 49.82 (+0.07), SCHA: 57.09 (+0.33), IBB: 352.60 (+7.27), ZSML: 26.50 (+0.18), VIOV: 101.05 (unch), SLYV: 105.93 (+0.14), RSCO: 86.92 (+1.06), RZV: 62.58 (-0.27), VB: 120.81 (+0.93), JKJ: 142.00 (+0.74), IWM: 123.37 (+0.76), VIOG: 109.65 (+0.52), SLYG: 186.14 (+1.53), RZG: 86.52 (+0.70)
Investors Are Best To Avoid The IShares Nasdaq Biotechnology ETF
Investing Healthcare - at Seeking Alpha - Mon Mar 02, 9:24AM CST
JNJ: 100.70 (+1.49), BIIB: 420.69 (+7.34), ACAD: 34.37 (-0.08), SPY: 208.03 (+2.20), PCYC: 255.99 (+1.01), GILD: 101.12 (+1.51), MRK: 57.04 (+0.84), ALXN: 178.39 (+1.50), IBB: 352.60 (+7.27), CELG: 120.32 (+2.59)
All That Cash
Derek Lowe - Seeking Alpha - Wed Feb 25, 1:12PM CST
From the LifeSciVC blog, here's a revealing comparison of the amount of money going into startups in this business. This is why I tend to get worked up about the number of stock buyback plans among the big pharma players. It would seem that...
XBI: 230.96 (+2.53), IBB: 352.60 (+7.27)
Manipulated Markets And How We Invest In Them
Individual Trader - at Seeking Alpha - Tue Feb 24, 6:06AM CST
SPY: 208.04 (+2.21), IBB: 352.60 (+7.27)
Biotech Weekly: 5 Factors Contributing To The Crazy Week That Was In Small Cap Biotech
Daniel Ward - at Seeking Alpha - Mon Feb 23, 7:40AM CST
HEB: 0.23 (unch), XBI: 230.96 (+2.53), IBIO: 0.83 (+0.14), IBB: 352.60 (+7.27), SPPI: 6.17 (-0.07), CLTX: 0.88 (+0.01)
Top Funds' Activity In Q4 2014
Leo Kolivakis - Seeking Alpha - Fri Feb 20, 2:04PM CST
Svea Herbst-Bayliss and Sam Forgione of Reuters report, Top U.S. hedge funds cut Apple stakes ahead of all-time high : Top U.S. hedge fund management firms, including David Einhorn's Greenlight Capital and Philippe Laffont's Coatue Management,...
HK: 1.54 (-0.11), XLB: 49.68 (-0.16), GREK: 10.61 (-0.07), XBI: 230.96 (+2.53), IBB: 352.60 (+7.27), NBG: 1.26 (+0.03), RRC: 45.74 (+0.45), RIG: 13.74 (+0.14), XLK: 41.85 (+0.36), SPR: 51.09 (+0.54), TWTR: 46.32 (-0.34), AAPL: 124.16 (+0.57), CSCO: 28.25 (+0.31), BHI: 59.39 (+0.52), XLE: 75.13 (+0.50), DVN: 58.23 (+0.53), FEYE: 42.00 (-0.04), XEC: 106.81 (+0.06), GSG: 19.07 (-0.25), NFLX: 419.43 (-18.97), GENE: 4.47 (-0.24), ROSG: 3.31 (-0.05), SBIO: 30.73 (+0.32), QQQ: 106.36 (+1.02), IDRA: 4.26 (+0.11), IWM: 123.37 (+0.76), BABA: 83.99 (+2.13)
These Stocks Are Steamrolling Everything in their Path…
Greg Guenthner - Daily Reckoning - Thu Feb 19, 8:24AM CST
This post These Stocks Are Steamrolling Everything in their Path… appeared first on Daily Reckoning . Today you’re hopping on a good ole fashioned steamroller for an honest day’s pay. Your job is to turn every underperforming industry and...
IBB: 352.60 (+7.27)
Look for Shares of iShares Nasdaq Biotechnology Index to Potentially Pullback after Yesterday's 1.04% Rise
Comtex SmarTrend(R) - Tue Feb 17, 4:05PM CST
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $322.73 to a high of $327.24. Yesterday, the shares gained 1.0%, which took the trading range above the 3-day high of $323.55 on volume of 882,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
IBB: 352.60 (+7.27)
Advances in Technology, Biotech Changing Humans' Relationship to the Environment
at The Street - Sat Mar 14, 5:05AM CDT
Steve Gullans, co-author of 'Evolving Ourselves,' says technology and biotechnology are creating a world of unnatural selection for humans.
QQQ: 106.36 (+1.02), XBI: 230.96 (+2.53), XLK: 41.86 (+0.37), IBB: 352.60 (+7.27)
3 Biotech ETFs Crushing the Market in 2015 - ETF News And Commentary
Eric Dutram - Zacks Investment Research - Fri Mar 13, 11:02AM CDT
If you are looking for impressive biotech funds consider this trio, as all of its members have gained more than 20 percent so far this year.
BIIB: 420.69 (+7.34), BBC: 33.89 (+0.44), BIB: 167.47 (+6.60), XBI: 230.96 (+2.53), IBB: 352.60 (+7.27), AMGN: 161.92 (+7.66)
Biotech: Too Many Red Flags To Ignore
Fabian Knigge - Seeking Alpha - Wed Mar 11, 8:56AM CDT
In recent financing rounds, Uber and Snapchat were valued at sky-high valuations of $41bn and $19bn, respectively. This prompted discussions about whether or not such valuations are justified or if there is another tech bubble on the horizon...
IBB: 352.60 (+7.27)
Women in ETFs Helping to Propel Careers and Industry Higher
at The Street - Mon Mar 09, 3:07PM CDT
Joanne Hill, the co-founder of Women in ETFs, describes the industry landscape and how the organization is designed to inspire and advance both careers and the industry to new highs.
XLB: 49.68 (-0.16), EWG: 29.94 (+0.75), XBI: 230.96 (+2.53), XLY: 75.90 (+0.74), EWQ: 25.77 (+0.43), IBB: 352.60 (+7.27), XLU: 44.31 (+0.83), TLT: 127.90 (+1.18), XRT: 99.55 (+0.63), XLV: 73.22 (+1.41), XLP: 48.69 (+0.41), SPY: 208.04 (+2.21), QQQ: 106.36 (+1.02), EWU: 18.07 (+0.18), DIA: 179.40 (+1.84), XLK: 41.86 (+0.37), IWM: 123.37 (+0.76), XLF: 24.57 (+0.25), XLE: 75.13 (+0.50)
ISIS Pharmaceuticals Has The Cash To Develop Its Expanding Product Pipeline
Emerging Equities - at Seeking Alpha - Fri Mar 06, 4:03PM CST
BIIB: 420.69 (+7.34), ISIS: 71.92 (+1.26), IBB: 352.60 (+7.27), GSK: 46.93 (+0.56), ETF: 12.45 (unch)
IBB Doesn't Fit The Mantra Of High-Risk High-Reward
Noah Kiedrowski - at Seeking Alpha - Fri Mar 06, 2:03PM CST
IBB: 352.60 (+7.27)
Gilead, Mylan, And J&J: Cheap Compared To Peers
Hedgephone - at Seeking Alpha - Fri Mar 06, 11:32AM CST
JNJ: 100.69 (+1.48), GILD: 101.12 (+1.51), IBB: 352.60 (+7.27), MYL: 60.76 (+1.00)
Either Way - The U.S. Is In Trouble
Individual Trader - at Seeking Alpha - Thu Mar 05, 1:24AM CST
SPY: 208.03 (+2.20), IBB: 352.60 (+7.27), UUP: 26.27 (-0.22), TLT: 127.90 (+1.18)
SBIO Vs. BBC: 2 Innovative Biotech ETFs Head-To-Head - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Wed Mar 04, 11:17AM CST
These newly launched products provide exposure to clinical biotechnology companies and have produced decent gains in the year-to-date frame.
SBIO: 30.73 (+0.32), BBC: 33.89 (+0.44), IBB: 352.60 (+7.27)
NASDAQ Hits 5,000: Does The IPO Market Suggest A Biotech Bubble?
Renaissance Capital IPO Research - Seeking Alpha - Tue Mar 03, 8:07AM CST
The NASDAQ Composite is fast approaching its all-time high from March 2000. On Monday it reached 5,000 for the first time since the tech bubble. Today's technology IPOs look much tamer in number than they did 15 years ago, but a boom in biotech...
QQQ: 106.36 (+1.02), XBI: 230.96 (+2.53), IBB: 352.60 (+7.27)
In 2015, Little Is The New Big
Nicholas Vardy - Seeking Alpha - Tue Mar 03, 12:40AM CST
Editor's note: Originally published on 24 February, 2015 When it comes to stocks, “big” is sometimes little — and “little” is sometimes big. Here I’m referring here to the recent performance of small-cap stocks...
RWJ: 57.33 (unch), IJT: 128.43 (+0.76), IJS: 117.61 (+0.21), IJR: 116.80 (+0.49), SBB: 51.07 (-0.32), VIOO: 104.87 (+0.38), SLY: 107.22 (+0.34), SAA: 118.52 (+1.20), SDD: 37.16 (-0.21), FYX: 49.82 (+0.07), SCHA: 57.09 (+0.33), IBB: 352.60 (+7.27), ZSML: 26.50 (+0.18), VIOV: 101.05 (unch), SLYV: 105.93 (+0.14), RSCO: 86.92 (+1.06), RZV: 62.58 (-0.27), VB: 120.81 (+0.93), JKJ: 142.00 (+0.74), IWM: 123.37 (+0.76), VIOG: 109.65 (+0.52), SLYG: 186.14 (+1.53), RZG: 86.52 (+0.70)
Investors Are Best To Avoid The IShares Nasdaq Biotechnology ETF
Investing Healthcare - at Seeking Alpha - Mon Mar 02, 9:24AM CST
JNJ: 100.70 (+1.49), BIIB: 420.69 (+7.34), ACAD: 34.37 (-0.08), SPY: 208.03 (+2.20), PCYC: 255.99 (+1.01), GILD: 101.12 (+1.51), MRK: 57.04 (+0.84), ALXN: 178.39 (+1.50), IBB: 352.60 (+7.27), CELG: 120.32 (+2.59)
All That Cash
Derek Lowe - Seeking Alpha - Wed Feb 25, 1:12PM CST
From the LifeSciVC blog, here's a revealing comparison of the amount of money going into startups in this business. This is why I tend to get worked up about the number of stock buyback plans among the big pharma players. It would seem that...
XBI: 230.96 (+2.53), IBB: 352.60 (+7.27)
Manipulated Markets And How We Invest In Them
Individual Trader - at Seeking Alpha - Tue Feb 24, 6:06AM CST
SPY: 208.04 (+2.21), IBB: 352.60 (+7.27)
Biotech Weekly: 5 Factors Contributing To The Crazy Week That Was In Small Cap Biotech
Daniel Ward - at Seeking Alpha - Mon Feb 23, 7:40AM CST
HEB: 0.23 (unch), XBI: 230.96 (+2.53), IBIO: 0.83 (+0.14), IBB: 352.60 (+7.27), SPPI: 6.17 (-0.07), CLTX: 0.88 (+0.01)
Top Funds' Activity In Q4 2014
Leo Kolivakis - Seeking Alpha - Fri Feb 20, 2:04PM CST
Svea Herbst-Bayliss and Sam Forgione of Reuters report, Top U.S. hedge funds cut Apple stakes ahead of all-time high : Top U.S. hedge fund management firms, including David Einhorn's Greenlight Capital and Philippe Laffont's Coatue Management,...
HK: 1.54 (-0.11), XLB: 49.68 (-0.16), GREK: 10.61 (-0.07), XBI: 230.96 (+2.53), IBB: 352.60 (+7.27), NBG: 1.26 (+0.03), RRC: 45.74 (+0.45), RIG: 13.74 (+0.14), XLK: 41.85 (+0.36), SPR: 51.09 (+0.54), TWTR: 46.32 (-0.34), AAPL: 124.16 (+0.57), CSCO: 28.25 (+0.31), BHI: 59.39 (+0.52), XLE: 75.13 (+0.50), DVN: 58.23 (+0.53), FEYE: 42.00 (-0.04), XEC: 106.81 (+0.06), GSG: 19.07 (-0.25), NFLX: 419.43 (-18.97), GENE: 4.47 (-0.24), ROSG: 3.31 (-0.05), SBIO: 30.73 (+0.32), QQQ: 106.36 (+1.02), IDRA: 4.26 (+0.11), IWM: 123.37 (+0.76), BABA: 83.99 (+2.13)
These Stocks Are Steamrolling Everything in their Path…
Greg Guenthner - Daily Reckoning - Thu Feb 19, 8:24AM CST
This post These Stocks Are Steamrolling Everything in their Path… appeared first on Daily Reckoning . Today you’re hopping on a good ole fashioned steamroller for an honest day’s pay. Your job is to turn every underperforming industry and...
IBB: 352.60 (+7.27)
Look for Shares of iShares Nasdaq Biotechnology Index to Potentially Pullback after Yesterday's 1.04% Rise
Comtex SmarTrend(R) - Tue Feb 17, 4:05PM CST
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $322.73 to a high of $327.24. Yesterday, the shares gained 1.0%, which took the trading range above the 3-day high of $323.55 on volume of 882,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
IBB: 352.60 (+7.27)
